최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한방사선종양학회지 = The Journal of the Korean soceity for therapeutic radiology and oncology, v.20 no.3, 2002년, pp.237 - 245
허승재 (성균관대학교 의과대학 삼성서울병원 치료방사선과) , 김보경 (성균관대학교 의과대학 삼성서울병원 치료방사선과) , 임도훈 (성균관대학교 의과대학 삼성서울병원 치료방사선과) , 신성수 (성균관대학교 의과대학 삼성서울병원 치료방사선과) , 이정은 (성균관대학교 의과대학 삼성서울병원 치료방사선과) , 강민규 (성균관대학교 의과대학 삼성서울병원 치료방사선과) , 안용찬 (성균관대학교 의과대학 삼성서울병원 치료방사선과)
Purpose : This study was conducted to evaluate the treatment results, prognostic factors, and complication rates after high dose rate (HDR) brachytherapy in patients with uterine cervix cancer who were treated with curative aim. Materials and Methods : Of 269 cervix cancer patients treated at the de...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Cancer PrevaIence Statistics. 21th Korean Central Central Cancer Registry Report., National Cancer Center, 2001
Coia L, Won M, Lanciano R, et aI. The patterns of care outcome study for cancer of the uterine cervix : Results of the secome study for cancer of the uterine cervix : Results of the second national practice survey. Cancer 1990;66:2451-2456
Perez CA, Breaux S, Madoc-Jones H, et aI. Radiation therapy alone in the treatment of carcinoma of uterine cervix: Analysis of tumor recurrence. Cancer 1983;54:1393-1402
Montana GS, FowIer WC, Varra MA, et aI. Carcinoma of the cervix, stage lll : Results of radiation therapy. Cancer 1986;57:148-154
EifeI PJ, Morris M, OswaId MJ. The influence of tumor size and growth habit on outcome of patients with FIGO stage IB spuamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1993;27:127-128
Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;48:201-211
Huh SJ, Ahn YC, Choi DR, et aI. Current status of high dose rate brachytherapy for uterine cervix cancer in Korea. The Journal of JASTRO 1996;8;277-281
Huh SJ. Current status of high dose rate brachytherapy in cervical cancer in Korea and optimal treatment schedule. J Korean Soc Ther Radiol Oncol 1998;16:357-366
Huh SJ, Lim DH, Ahn YC, et aI. Effect of customized small bowel displacement system in pelvic irradiation. Int J Radiat Oncol Biol Phys 1998;40:623-627
Chassagne D, Sismondi P, Horiot JC et aI. A glossary for reporting complications of treatment in gynecological cancers Radiother Oncol 1993;26:195-202
International Commission on Radiation Units and Measurements Report 38, Dose and Volume Specifications for Reporting Intracavitary Therapy in Gynecology. International Commission on Radiation Units and Meacurements. Bethesda, MD, 1985
Suh CO, Kim KE, Loh JK, et aI. Treatment of carcinoma of the uterine cervix with high dose rate intracavitary irradiation using Ralstron. The Journal of the Korean Society of Therapeutic Radiology 1990;8:231-240
Lee SW, Suh CO, Chung EJ, Kim GE. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma. Int J Radiat Oncos Biol Phys 2002;52:1338-1344
Huh SJ. The result of curative radiotherapy for carcinoma of uterine cervix. The Journal of the Korean Society of Therapeutic Radiology 1993;11:143-149
Moon CW, Jeung TS, Yum, HY. Analysis of radiotherapy associated factors in stage IIb carcinoma of uterine cervix. The Journal of the Korean Society of Therapeutic Radiology 1990;8:241-254
Kim OB, Choi TJ, Kim JH, et aI. Carcinoma of uterine cervix treated with high dose rate intracavitary irradiation : pattern of failue. The Journasl of the Korean Society of Therapeutic Radiology 1993;11:369-376
KiI WJ., Chun M, Kang S, et aI. Radiotherapy results in stage IIB uterine cervix cervix cancer. J Korean Soc Ther Radiol Oncol 2001;19:345-352
Shigematsu Y, Nishiyama K, Masaki N, et aI. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitaty radiotherapy with high dose rate-acomparative study with low dose rate system. Int J Radiat Oncol Biol Phys 1983;9:351-356
EifeI PJ. High dose rate brachytherapy for carcinoma of the cervix: High tech or high risk? Int J Radiat Oncol Biol Phys 1996;24:383
Okawa T, Sakada S, Kita-Okawa M, et aI. Comparison between high dose rate and low dose rate brachytherapy for cervical cancer : Japanese experienoe with treatment and complications(1975-1985). The Journal of JASTRO 1996;8:135-142
Shin KH, Huh SJ, Chie EK, et aI. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer : in vivo dosimetric analysis. Radiation Medicine 1999;17:289-293
Lim, DH, Huh SJ, Shin KH, Ahn YC, Kim DY. In Vivo dosimetric analysis between rectal dose and rectao complication in patients with cerrvix cancer treated with high dose rate intracavitary radiotherapy. Int J Radiat Oncol Biol Phys 2001(S1);51:329-330
Kapp KS, StueckIschweiger GF, Kapp DS, et aI. Carcinoma of the cervix: analysis of compIications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol 1997;42:143-153
Huh SJ, Kim B, Shin SS, et aI. Pelvic insufficiency fracture after pelvic irradiation in uterine cervix cancer. J Korean Soc Ther Radiol Oncol 2001;19(S):48
Huh SJ, Kim BK, Kang MK, et aI. Pelvic Insufficiency Fracture after Pelvic Irradiation in Uterine Cervix Cancer. Gynecol Oncol 2002;86:264-268
Hsu WL, Wu CJ, Jen TM, et aI. Twice-a-day fractionated high vs. continuous low dose rate intracavitary therapy in the radical treatment of cervical cancer : A nonrandomized comparison of treatment results. Int JRadiat Oncol Biol Phys 1995;32:1425-1431
Arai T, Nakano T, Morita S, et aI. High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix : A 20-year experience. Cancer 1992;69:175-180
Arai T, Nakano T, Morita S, et aI. Longterm treatment result of radiotherapy for cervical spuamous cell cancer. The Journal of JASTRO 1997; 9:146(abst)
Chatani M, Matayoshi Y, Masaki N, Inoue T. High dose rate intracavitary irradiation for carcinoma of the uterine cervix cancer. The adverse effect of treatment prolongation. Strahlenther Onkol 1997;173:379-384
Petereit DG, Sarkaria JN, ChappeII R, et aI The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1301-1307
DeIaIoye JF, Coucke PA, PampaIIona S, PeItecu G, De Grandi P. Radiation therapy duration influences overall survival in patients with cervical carcinoma. Int J Gynecol Obstet 1997;57:295-303
EifeI PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE. Patterns of radiotherapy practice for patients with spuamous carcinoma of the uterine cervix : patterns of care atudy. Int J Radiat Oncol Biol Phys 1999;43:351-358
Lehman M, Thomas G. Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer? Int J Gynecol Cancer 2001;11:87-99
NCI. Concurrent chemoradiation for cervical cancer. February 22. 1999 Washington D.C
Potter, R, Knocke TH. The potential of 3-D conformal brachytherapy and external beam radiotherapy in cervix cancer. StrahIenther Onkol 2001;177:641-642
Pearcy R, Brundage M, Drouin P, et aI. Phase III trial comparing radical radiotherapy with and without cispIatin chemotherapy in patients with advanced spuamous ceII cancer of the cervix. J CncoI 2002;20:966-972
※ AI-Helper는 부적절한 답변을 할 수 있습니다.